Ann Rheum Dis. 1981 Aug;40(4):355-9.

Azathioprine in rheumatoid arthritis: double-blind study of full versus half doses versus placebo.

Woodland J, Chaput de Saintonge DM, Evans SJ, Sharman VL, Currey HL.

Abstract

To test whether azathioprine in effective in rheumatoid arthritis in doses smaller than those normally used the drug was tested at 2 dosage levels, 2.5 and 1.25 mg/kg/day (2.5 AZ and 1.25 AZ), against placebo under double-blind conditions over 24 weeks. Dropouts were 7 out of 15 in the 2.5 AZ group, 4 out of 14 in the 1.25 AZ group, and 2 out of 13 in the placebo group. Some significant improvement occurred in all 3 groups, including those on placebo. However, the 2.5 AZ group fared significantly better than the placebo group, while the 1.25 AZ group results tended to fall between the other 2 groups. We conclude that, in order to obtain the reported effectiveness of azathioprine in rheumatoid arthritis, it is necessary to start treatment with 2.5 mg/kg/day. Halving this dosage reduces the effectiveness of the drug.

PMID:: 7020612; [PubMed - indexed for MEDLINE]
PMCID:: PMC1000728

Free PMC Article

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

Azathioprine

LinkOut - more resources

Full Text Sources

Medical

Molecular Biology Databases

AZATHIOPRINE - HSDB

Supplemental Content

Save items

Related citations in PubMed

Azathioprine versus placebo in patients with juvenile rheumatoid arthritis: a single center double blind comparative study. [J Rheumatol. 1986]
Azathioprine versus placebo in patients with juvenile rheumatoid arthritis: a single center double blind comparative study.
Kvien TK, Høyeraal HM, Sandstad B. J Rheumatol. 1986 Feb; 13(1):118-23.
Disparity between clinical and immune responses in a controlled trial of azathioprine in rheumatoid arthritis. [Eur J Clin Pharmacol. 1976]
Disparity between clinical and immune responses in a controlled trial of azathioprine in rheumatoid arthritis.
GOEBEL KM, Janzen R, Joseph K, Börngen U. Eur J Clin Pharmacol. 1976 Mar 22; 09(5-6):405-10.
A placebo-controlled, randomized, double-masked, variable dosage, clinical trial of azathioprine with and without methylprednisolone in multiple sclerosis. [Neurology. 1989]
A placebo-controlled, randomized, double-masked, variable dosage, clinical trial of azathioprine with and without methylprednisolone in multiple sclerosis.
Ellison GW, Myers LW, Mickey MR, Graves MC, Tourtellotte WW, Syndulko K, Holevoet-Howson MI, Lerner CD, Frane MV, Pettler-Jennings P. Neurology. 1989 Aug; 39(8):1018-26.
Review Cytotoxic agents in the treatment of rheumatoid arthritis. [South Med J. 1978]
Review Cytotoxic agents in the treatment of rheumatoid arthritis.
Davis JD, Muss HB, Turner RA. South Med J. 1978 Jan; 71(1):58-64.
Review Azathioprine for rheumatoid arthritis. [Cochrane Database Syst Rev. 2000]
Review Azathioprine for rheumatoid arthritis.
Suarez-Almazor ME, Spooner C, Belseck E. Cochrane Database Syst Rev. 2000; (2):CD001461.

See reviews... See all...

Cited by 3 PubMed Central articles

Management of rheumatoid arthritis. [Can Fam Physician. 1984]
Management of rheumatoid arthritis.
Carette S. Can Fam Physician. 1984 Jun; 30:1363-8.
Review A rheumatological dilemma: is it possible to modify the course of rheumatoid arthritis? Can we answer the question? [Ann Rheum Dis. 1985]
Review A rheumatological dilemma: is it possible to modify the course of rheumatoid arthritis? Can we answer the question?
Pullar T, Capell HA. Ann Rheum Dis. 1985 Feb; 44(2):134-40.
Review Compliance in clinical trials. [Ann Rheum Dis. 1989]
Review Compliance in clinical trials.
Pullar T, Kumar S, Feely M. Ann Rheum Dis. 1989 Oct; 48(10):871-5.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
References for this PMC Article
Citation referenced in PubMed article. Only valid for PubMed citations that are also in PMC.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Free in PMC
Free full text articles in PMC
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Azathioprine in rheumatoid arthritis: double-blind study of full versus half dos...
Azathioprine in rheumatoid arthritis: double-blind study of full versus half doses versus placebo.
Ann Rheum Dis. 1981 Aug ;40(4):355-9.

PubMed
Human C4-binding protein. II. Role in proteolysis of C4b by C3b-inactivator.
Human C4-binding protein. II. Role in proteolysis of C4b by C3b-inactivator.
J Exp Med. 1978 Oct 1 ;148(4):1044-51.

PubMed
The effects of intermittent positive pressure breathing on patients with respira...
The effects of intermittent positive pressure breathing on patients with respiratory muscle weakness.
Am Rev Respir Dis. 1981 Aug ;124(2):132-7.

PubMed
Leo Kanner, M.D. 1894--1981.
Leo Kanner, M.D. 1894--1981.
Am J Psychiatry. 1981 Aug ;138(8):1122-5.

PubMed
Magnesium deficiency. Etiology and clinical spectrum.
Magnesium deficiency. Etiology and clinical spectrum.
Acta Med Scand Suppl. 1981 ;647:125-37.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: